Degenerative disc disease is one of the most common causes of chronic low back pain, affecting millions of people worldwide. It occurs when the intervertebral discs, the cushioning structures between the bones of the spine, begin to break down over time. This degeneration leads to reduced disc height, loss of hydration, inflammation, and structural instability, all of which contribute to pain and reduced mobility. While current treatments can help manage symptoms, they do not reverse the underlying damage. This limitation has led researchers to explore regenerative approaches, including stem cell therapy, as a potential way to restore disc health rather than simply manage pain.
In this article, Munda and Velnar focus on the application of stem cell therapy for treating spinal pathologies, particularly intervertebral disc (IVD) degeneration.
Understanding Disc Degeneration
The intervertebral disc plays a critical role in absorbing shock and maintaining flexibility in the spine. At the center of the disc is the nucleus pulposus, a gel-like structure rich in water and specialized cells that produce the extracellular matrix. Over time, these cells decline in number and function, triggering a progression of degenerative changes. The disc begins to lose important components such as proteoglycans and type II collagen, which are essential for maintaining hydration and structural integrity.
As degeneration progresses, inflammation increases. Cells within the disc release inflammatory molecules such as interleukins and tumor necrosis factor, which further accelerate tissue breakdown. Blood vessels and nerve fibers may grow into areas where they are not normally present, contributing to pain. These structural and biochemical changes can lead to disc herniation, nerve compression, and chronic lower back pain.
Limitations of Current Treatments
Conventional treatments for degenerative disc disease focus primarily on symptom relief rather than repair. These approaches include medications, physical therapy, injections, and, in more severe cases, surgery. Procedures such as spinal fusion or disc replacement can reduce pain, but they often alter spinal mechanics and may lead to degeneration in adjacent segments over time.
Importantly, none of these treatments restore the native disc tissue or reverse the degenerative process. This gap between symptom management and true regeneration has driven interest in stem cell-based therapies that aim to repair damaged tissue at a biological level.
Rationale for Stem Cell Therapy in Degenerative Disc Disease
Stem cells have unique properties that make them attractive for regenerative medicine. They can self-renew and differentiate into specialized cell types, and they also release bioactive molecules that support healing. In the context of disc degeneration, stem cells may help restore the extracellular matrix, reduce inflammation, and promote the survival of native disc cells.
Among the different types of stem cells, mesenchymal stem cells (MSCs) are the most widely studied for spinal applications. These cells can be obtained from bone marrow, adipose tissue, or other sources and have demonstrated the ability to differentiate into disc-like cells under certain conditions. In addition to their differentiation potential, MSCs exert strong anti-inflammatory and regenerative effects through the release of signaling molecules.
Mechanisms of Stem Cell Action
Stem cell therapy in degenerative disc disease appears to work through multiple mechanisms. One potential mechanism is differentiation, where stem cells transform into cells resembling those found in the nucleus pulposus. These cells can then contribute directly to rebuilding the disc structure.
However, increasing evidence suggests that much of the therapeutic benefit comes from paracrine signaling rather than direct replacement. Stem cells release growth factors, cytokines, and extracellular vesicles that influence the surrounding environment. These signals can reduce inflammation, stimulate native cells, and promote tissue repair.
Extracellular vesicles, including exosomes, are particularly important in this process. They act as carriers of molecular signals, delivering proteins and genetic material that regulate cell behavior. This has led to growing interest in cell-free therapies that use these vesicles instead of whole cells.
Evidence from Animal Studies
Preclinical studies in animal models have shown encouraging results. In experiments involving rodents and rabbits, stem cell implantation has been associated with increased disc height, improved hydration, and restoration of extracellular matrix components. These changes suggest that stem cells can help reverse some of the structural damage caused by degeneration.
In addition to structural improvements, studies have demonstrated reduced inflammation and decreased levels of pro-inflammatory cytokines. Some models have also shown improved functional outcomes, such as reduced pain behaviors and better mobility. Even in cases where imaging changes were limited, animals often exhibited meaningful improvements in function, highlighting the complex relationship between structure and symptoms.
Early Clinical Findings
Human studies, although still limited, have also reported promising outcomes. Patients receiving stem cell injections into degenerated discs have shown reductions in pain and improvements in quality of life. In some cases, imaging studies have indicated increased disc hydration or reduced disc bulging.
However, these studies often involve small sample sizes and lack consistent control groups, making it difficult to draw definitive conclusions. Additionally, degenerative disc disease can sometimes improve on its own, further complicating interpretation. Larger, well-controlled clinical trials are needed to determine the true effectiveness and long-term benefits of stem cell therapy.
Challenges and Limitations
Despite promising results, the authors highlight several challenges that must be addressed before stem cell therapy can become a standard treatment. One of the most significant obstacles is the harsh microenvironment of the intervertebral disc. The disc is largely avascular, meaning it has a limited blood supply. This creates a low-oxygen, nutrient-poor environment that can reduce the survival of implanted cells.
Another challenge is understanding the exact mechanism of action. While differentiation into disc cells is possible, it may not be the primary driver of regeneration. Instead, the effects of stem cells may rely more on their ability to influence surrounding cells through signaling pathways.
Researchers are exploring strategies to improve outcomes, including preconditioning stem cells to better tolerate harsh environments, using biomaterials to support cell survival, and combining stem cell therapy with other treatments. Advances in genetic engineering and tissue engineering may also help enhance the effectiveness of these therapies.
The Future of Regenerative Spine Care
Stem cell therapy represents a potential shift in how degenerative disc disease is treated. Rather than focusing solely on symptom management, regenerative approaches aim to restore the structure and function of the disc itself. This could lead to more durable outcomes and reduce the need for invasive surgical procedures.
Future research will need to address key questions related to optimal cell type, delivery methods, dosing, and patient selection. Improved experimental models and long-term clinical studies will be essential for translating early findings into reliable clinical applications.
Clinical Outlook and Future Implications
Degenerative disc disease remains a major source of chronic pain and disability, with current treatments offering limited ability to repair damaged tissue. Stem cell therapy, particularly using mesenchymal stem cells, has shown promising potential to address the underlying causes of degeneration by reducing inflammation, supporting tissue repair, and restoring disc structure.
While significant challenges remain, ongoing research continues to refine these approaches and improve their effectiveness. As the field of regenerative medicine advances, Munda and Velnar conclude that stem cell therapy may play an increasingly important role in transforming the treatment of spinal conditions and improving the lives of patients with chronic back pain.
Source: Munda M, Velnar T. Stem cell therapy for degenerative disc disease: Bridging the gap between preclinical promise and clinical potential. Biomol Biomed. 2024 Mar 11;24(2):210-218. doi: 10.17305/bb.2023.9518. PMID: 37669102; PMCID: PMC10950333.